196 related articles for article (PubMed ID: 12099654)
1. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
Meyer T; Merkel S; Göhl J; Hohenberger W
Eur J Surg Oncol; 2002 Jun; 28(4):424-30. PubMed ID: 12099654
[TBL] [Abstract][Full Text] [Related]
2. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
3. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
4. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
6. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
7. [Axillary recurrence after lymph node excision in malignant melanoma].
Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H; Hetschko I
Langenbecks Arch Chir; 1993; 378(1):4-11. PubMed ID: 8437502
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
9. Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?
Herman K; Wysocki WM; Skotnicki P; Tabor J; Luczyńska E; Komorowski AL
World J Surg; 2009 Mar; 33(3):469-74. PubMed ID: 19148700
[TBL] [Abstract][Full Text] [Related]
10. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
12. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
15. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
16. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
17. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
19. Lymph node dissection for melanoma using tumescence local anaesthesia: an observational study.
Kofler L; Breuninger H; Häfner HM; Schweinzer K; Schnabl SM; Eigentler TK; Leiter U
Eur J Dermatol; 2018 Apr; 28(2):177-185. PubMed ID: 29620000
[TBL] [Abstract][Full Text] [Related]
20. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]